Variant #0000052316 (NC_000011.9:g.3846254G>C, NM_001256240.1:c.530G>C (PGAP2))
| Individual ID |
00028965 |
| Chromosome |
11 |
| Allele |
Both (homozygous) |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
- |
| Clinical classification |
pathogenic |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.3846254G>C |
| DNA change (hg38) |
g.3825024G>C |
| Published as |
- |
| ISCN |
- |
| DB-ID |
PGAP2_000002 |
| Variant remarks |
Substitution between transmembrane segments 3 and 4 in the Golgi lumen. Predicted to be pathogenic. In vitro CHO cells study showed that the mutant protein was expressed but had significantly decreased activity compared to wildtype. Lymphoblastoid cells of patient showed normal levels of DAF and CD59, which suggest a hypomorphic effect. |
| Reference |
PubMed: Hansen et al 2013 |
| ClinVar ID |
- |
| dbSNP ID |
- |
| Origin |
Germline |
| Segregation |
yes |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
4.0E-5 View details |
| Owner |
Philippe Campeau |
| Database submission license |
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International |
| Created by |
Philippe Campeau |
| Date created |
2015-01-09 22:53:22 +01:00 (CET) |
| Date last edited |
N/A |

Variant on transcripts
Screenings
|